Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Primary safety objective: To evaluate the dose-response relationship for QT effects of AZD1305 Primary efficacy objective: To demonstrate a dose-response relationship for AZD1305 given intravenously for conversion of AF to SR, and a statistically significant pair-wise difference for at least one of the dose levels of AZD1305 versus placebo
Critère d'inclusion
- Atrial fibrillation clinically indicated for cardioversion